As per this study, the Global Interventional Pulmonology Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2027 with a CAGR of XX%.
Interventional pulmonology is the minimally invasive technique to diagnose and treat lungs and chest disorders such as lung cancer, airway disorder and pleural diseases. It is also known as IP or interventional pulmonary medicine. This technique minimizes the number of procedures to treat the medical condition and risk of associated complication. It is performed by pulmonologist in hospitals, emergency center and clinic.
The rising prevalence of lungs and chest medical conditions is driving the market growth. Various awareness campaigns regarding asthma, COPD and other pulmonary diseases undertaken by governments and healthcare providers are fueling the market growth. Moreover, rise in disposable income resulting into increase in healthcare expenditure is further boosting growth of the market. However, emergence of alternative methods is likely to hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of interventional pulmonology.
The broad interventional pulmonology market has been sub-grouped into procedure. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Flexible Bronchoscopy
- Rigid Bronchoscopy
- Bronchoalveolar Lavage
- Lung Biopsy
- Bronchial Stent
- Balloon Bronchoplasty
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for interventional pulmonology in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Interventional Pulmonology Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the interventional pulmonology market include Boston Scientific Corporation, BTG, plc., ENDO-FLEX GmbH., Ethicon, Inc., HealthTronics, Inc., Karl Storz, Medtronic, plc., Pulmonx, Inc., Terumo Corporation and Varian Medical Systems, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.